Hereditary Sensory and Autonomic Neuropathies

15 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Nervous System Diseases, Neurodegenerative Diseases, Peripheral Nervous System Diseases, Polyneuropathies

Narrower: Dysautonomia, Familial 1

Treatments and conditions

Hereditary Sensory and Autonomic Neuropathies
Treatment and conditionWhere it standsTrials
Capivasertib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carboplatin + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carboplatin + ELRAGLUSIB + Paclitaxel for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexmedetomidine hydrochloride for dysautonomia, familialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Doxorubicin hydrochloride + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elraglusib for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + NAB-PACLITAXEL + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + Metformin + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
FULVESTRANT + Tersolisib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lomustine + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ROC-101 for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TAMOXIFEN + FULVESTRANT + ANASTROZOLE + Abemaciclib + Letrozole + IMLUNESTRANT + Tersolisib + Palbociclib + Exemestane + Ribociclib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tersolisib for hereditary sensory and autonomic neuropathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.